News Conference News AHA 2017 Low-Dose Rivaroxaban Plus Aspirin Lowers Some Costs in COMPASS, but Full Economic Impact Unclear Todd Neale November 14, 2017
News Daily News Secondary Prevention Lagging Behind in Women With Established Coronary Disease Todd Neale September 22, 2017
News Conference News ESC 2017 ESC Releases Revamped DAPT Guidance Focusing on Personalized Approach Todd Neale September 01, 2017
News Daily News Pregnancy-Associated SCAD Is a Particularly High-Risk Subset of the Condition Todd Neale July 17, 2017
News Daily News Fish Oils: Yes for HF and Secondary Prevention, No for the General Population, Says AHA Michael O'Riordan March 15, 2017
News Daily News NOACs Seem to Perform Just Fine in Patients With A-fib and Most Types of Valvular Disease Todd Neale March 14, 2017
News Conference News ACC 2017 ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More Shelley Wood March 10, 2017